Industry | 2020.08.18
Catalent to Discuss a Scalable Gene Therapy Manufacturing Process and Early Development Considerations for Orphan Drugs at Upcoming Industry Congress
Catalent, the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products, today announced it will present at the upcoming World Orphan Drug Congress Annual Meeting, which will take place virtually on Aug. 24 – 26, 2020.
(PRWeb August 18, 2020)
Read the full story at https://www.prweb.com/releases/catalent_to_discuss_a_scalable_gene_therapy_manufacturing_process_and_early_development_considerations_for_orphan_drugs_at_upcoming_industry_congress/prweb17332495.htm
For more information, please visit
https://www.prweb.com/releases/catalent_[...]try_congress/prweb17332495.htm
